Townhall.com, Where Your Opinion Counts
Talk Radio:   Bill Bennett   Mike Gallagher   Dennis Prager   Michael Medved   Hugh Hewitt   
BREAKING NEWS  LeftArrow - Townhall.com : Conservative, Political, Republican   RightArrow - Townhall.com : Conservative, Political, Republican  
Columns, funnies & more in your inbox!
  • Check the boxes and send us your email address to receveive your free newsletter
  • Your daily must-read of conservative columns, cartoons and news. Coulter, Sowell, Krauthammer and more.
  • Townhall.com’s weekly inside scoop on what’s happening behind the scenes in the world of politics. When news breaks, we report.
  • Signup to receive the latest daily Townhall cartoons
Saturday, October 17, 2009
Shannon Zimmerman :: Townhall.com Columnist
Prep for the Pullback Now
by Shannon Zimmerman
Vote on It:
Average Vote:
[+] Text [-]
 
 
Poll
Will the Dems' health care Christmas Present to America be an improvement or detriment to our health care system?


Sure, we all feel like geniuses now, right? We stuck it out -- "it" being the worst economic crisis since the Great Depression -- and have now enjoyed fat and happy double-digit gains ever since the market hit bottom in March.

There's surely more to come, right? Right?!

Survey says …
Who knows? We Fools pride ourselves not on making market calls, which are a great way to get slapped silly by the market's invisible hand. Rather, we take pride in our fundamental focus. Is a company's market share likely to shrink or grow? Has its management team delivered the goods over the long haul while deftly navigating both up markets and down? And in terms of valuation, does the firm's stock look like a blue-light special or a high-end luxury item?

In my experience, that last element -- valuation -- is often the toughest taco to crack. Some companies never look cheap, after all. Others that appear to be bargains may turn out to be value traps instead. Still, in general terms, one thing remains true: When a company sports moon-shot multiples, there's little opportunity to cushion the blow when the overall market hits the skids or when the company itself blows up.

The higher they fly, the harder they fall
For example, take Research In Motion and Google . The former has gained 65% year to date, even after factoring in its recent dramatic slide. The latter has increased by some 80%. Yet sneaking a peek at this illustration of recent historyshould be instructive for folks who currently own either company's shares, as well as Fools who may be considering a purchase.

Could investors have foreseen the slide that chopped at least 50% off each company's value? Perhaps not, but if they'd tuned into each firm's valuation, savvy investors might have dodged a bullet by taking gains, waiting for valuation gravity to work its magic.

Shortly before its 2008 slide began, Research In Motion traded at a level that priced in more than 60 times the previous year's earnings. Google, meanwhile, sported a P/E in the 50s back when we were celebrating New Year's 2008. And while both companies have since recovered, RIMM now trades with a P/E just south of 20, while Google has clawed its way back to 38.

Bottom line: A little valuation discipline can go a long way. When an all-but-inevitable market pullback arrives, highfliers can be sitting ducks -- and future bargains, at least in relative terms.

Good company, lousy investment
Along those same lines -- and following robust run-ups of more than 40% over the last three months alone -- Citigroup (NYSE: C) and Freeport-McMoRan Copper & Gold (NYSE: FCX) could be cruising for proverbial bruisings. That goes double for Southern Copper (NYSE: PCU), whose current P/E hovers above 50 -- more than five times the company's average over the last half-decade.

Last but not least: Caterpillar (NYSE: CAT), which is currently priced at nearly 30 times analysts' earnings estimates for this fiscal year. Given the eternal -- and generally erroneous -- optimism of Wall Street's Gucci-loafer set, that's way too rich for my blood.

That's particularly true, moreover, given the company's deep economic sensitivity -- and the still-plentiful number of long-haul overachievers trading on the cheap: Johnson & Johnson (NYSE: JNJ), Pfizer (NYSE: PFE), and PepsiCo (NYSE: PEP), for example, currently weigh in with multiples below the broader market's and their own five-year averages. Continued...

1 2
| Full Article & Comments | Next >
Share:
Vote on It:
Average Vote:
 
About The Author

Shannon Zimmerman, Ph.D., is a specialist on mutual funds

Be the first to read Shannon Zimmerman column. Sign up today and receive Townhall.com delivered each morning to your inbox.

Sign Up to Post Your CommentsSign Up to Post Your Comments
If you are already registered, click here to login. Otherwise, please take a few seconds to register with Townhall.com. Once you sign up, you’ll be able to post your comments immediately, use the action center, get podcasts, and more!
Note: Fields marked with a red asterisk (*) are required.
Salutation:
First Name:
*
Last Name:
*
Email:
*
Nickname:
*
Note: Nick name will be shown when you post comments.
Address 1:
*
Address 2:
City:
*
State:
*
Zip:
*
Phone:
      
Your daily must-read of conservative columns, cartoons and news. Coulter, Sowell, Krauthammer and more.
(Bi-Weekly) We highlight the best opportunities from our partners for surveys, action items and more.